Abbott Laboratories (ABT) Divestments (2015 - 2021)

Abbott Laboratories has disclosed Divestments across 5 years of filings, most recently posting $86.0 million for Q3 2021.

• In Q3 2021, Divestments changed N/A year-over-year to $86.0 million; the TTM figure through Dec 2022 stood at $86.0 million (down 10.42% YoY), while the FY2024 annual figure was $1.0 million, down 97.5% from the prior year.
• Divestments came in at $86.0 million for Q3 2021 at Abbott Laboratories, up from $10.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $5.5 billion in Q1 2017 to a low of -$29.0 million in Q3 2017.
• Average Divestments over 3 years is $1.0 billion, with a median of $48.0 million recorded in 2020.
• The largest YoY upside for Divestments was 21788.0% in 2017 against a maximum downside of 21788.0% in 2017.
• Over 3 years, Divestments stood at $600.0 million in 2017, then plunged by 98.33% to $10.0 million in 2020, then surged by 760.0% to $86.0 million in 2021.
• Per Business Quant data, the three most recent Divestments figures were $86.0 million in Q3 2021, $10.0 million in Q4 2020, and $600.0 million in Q4 2017.